IHS Chemical Week

Omnova beats estimates despite net income decline

11:24 AM MDT | June 27, 2013

Omnova’s fiscal second-quarter net income declined 58.6% year-on-year (YOY), to $2.9 million, on sales down 11.9%, to $270.8 million. Adjusted earnings from continuing operations, excluding restructuring and refinancing costs, totaled $7.1 million, or 16 cts/share, down 14.5% YOY but ahead of analysts’ consensus of 15 cts/share, as reported by Thomson Reuters. Omnova’s fiscal second-quarter ended on 31 May. "We have made a number of structural improvements that we expect will contribute to improved results during the remainder of the year, including new...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 


Forgot your user ID or password? Click here to have it sent to you.



If you are not yet a subscriber and would like to access the turnkey information found only in Chemweek’s Business Daily, subscribe now and you’ll get the most important news of the chemical industry delivered directly to your inbox—every day.

Sign up for a FREE 15-day trial of IHS Chemical Week Business Daily

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa